Inflammatory myopathy occurring shortly after severe acute respiratory syndrome coronavirus 2 vaccination: two case reports.

Vutipongsatorn, Kritchai; Isaacs, Anthony; Farah, Ziad

Vutipongsatorn, Kritchai; Isaacs, Anthony; Farah, Ziad.

Afiliación

Vutipongsatorn K; Department of Rheumatology, Northwick Park Hospital, London North West University Healthcare NHS Trust, Watford Rd, Harrow, HA1 3UJ, UK.
Isaacs A; Faculty of Medicine, Imperial College London, Exhibition Rd, South Kensington, London, SW7 2BX, UK.
Farah Z; Department of Rheumatology, Northwick Park Hospital, London North West University Healthcare NHS Trust, Watford Rd, Harrow, HA1 3UJ, UK.

J Med Case Rep ; 16(1): 57, 2022 Jan 30.

Article en En | MEDLINE | ID: mdl-35094715

Asunto(s)

COVID-19; Miositis; Anciano; Vacuna BNT162; Femenino; Humanos; Metilprednisolona; Persona de Mediana Edad; Miositis/tratamiento farmacológico; SARS-CoV-2; Vacunación

Palabras clave

Coronavirus disease 2019; Idiopathic inflammatory myopathies; Messenger ribonucleic acid vaccine; Severe acute respiratory syndrome coronavirus 2

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: COVID-19 / Miositis Límite: Aged / Female / Humans / Middle aged Idioma: En Revista: J Med Case Rep Año: 2022 Tipo del documento: Article País de afiliación: Reino Unido Pais de publicación: Reino Unido

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google